Previous Close | 10.33 |
Open | 10.30 |
Bid | 10.10 x 1000 |
Ask | 12.49 x 800 |
Day's Range | 10.17 - 10.45 |
52 Week Range | 10.05 - 19.26 |
Volume | |
Avg. Volume | 61,641 |
Market Cap | 198.595M |
Beta (5Y Monthly) | 0.77 |
PE Ratio (TTM) | 9.72 |
EPS (TTM) | 1.05 |
Earnings Date | Nov 02, 2022 - Nov 07, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Mar 26, 2021 |
1y Target Est | 18.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for NATR
Joining us today are Nature's Sunshine's CEO, Terrence Moorehead; CFO, Joseph Baty; and general counsel, Nathan Brower. As expected, second quarter margins contracted due to inflationary pressures on cost of goods, inventory reserves associated with the conflict in Ukraine and continued investment in our growth strategies.
LEHI, Utah, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (Nature’s Sunshine), a leading natural health and wellness company of high-quality herbal and nutritional products, reported financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Financial Summary vs. Same Year-Ago Quarter Net sales were $104.2 million compared to $109.0 million.GAAP net income was $1.0 million, or $0.03 per diluted share, compared to $6.8 million, or $0.32 p
Nature's Sunshine Products, Inc. (Nasdaq: NATR) (Nature's Sunshine), a leading natural health and wellness company—and one of a very few supplement companies that develop, test, and manufacture their own products—received three awards from Comparably recognizing its leadership and efforts to create a diverse workplace. The corporate brand reputation platform recognized Nature's Sunshine with the following awards: